PHARMACOKINETIC BASIS OF INTRAVENOUS DRUG DELIVERY

被引:5
|
作者
GLASS, PSA
DOHERTY, D
JACOBS, JR
QUILL, TJ
机构
来源
BAILLIERES CLINICAL ANAESTHESIOLOGY | 1991年 / 5卷 / 03期
关键词
D O I
10.1016/S0950-3501(05)80050-9
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
We have seen in recent years the release of numerous intravenous anaesthetic agents whose duration of action is relatively short, thus lending themselves to administration via continuous infusion. Clinical studies have clearly demonstrated the advantages of continuous infusion over repeated bolus dosing. These two factors have prompted pump manufacturers to produce devices that simplify the administration of intravenous anaesthetics by continuous infusion. It is concentration rather than dose that results in the desired effect. Utilizing pharmacokinetic principles, it is possible to provide automated drug delivery systems whereby the device can produce a clinician-specified drug concentration. In addition, where there is an easily measurable end-point, closed-loop feedback control can be implemented automatically to control the desired parameter within a very narrow range. With this rapid development in intravenous drug delivery, it becomes imperative that clinicians familiarize themselves with these new drug delivery devices so that they can use them optimally to care for their patients. © 1991 Baillière Tindall.
引用
收藏
页码:735 / 775
页数:41
相关论文
共 50 条
  • [1] PHARMACOKINETIC AND PHARMACODYNAMIC BASIS FOR PEPTIDE DRUG DELIVERY SYSTEM-DESIGN
    BREIMER, DD
    JOURNAL OF CONTROLLED RELEASE, 1992, 21 (1-3) : 5 - 10
  • [2] Pharmacokinetic aspects of retinal drug delivery
    del Amo, Eva M.
    Rimpela, Anna-Kaisa
    Heikkinen, Emma
    Kari, Otto K.
    Ramsay, Eva
    Lajunen, Tatu
    Schmitt, Mechthild
    Pelkonen, Laura
    Bhattacharya, Madhushree
    Richardson, Dominique
    Subrizi, Astrid
    Turunen, Tiina
    Reinisalo, Mika
    Itkonen, Jaakko
    Toropainen, Elisa
    Casteleijn, Marco
    Kidron, Heidi
    Antopolsky, Maxim
    Vellonen, Kati-Sisko
    Ruponen, Marika
    Urtti, Arto
    PROGRESS IN RETINAL AND EYE RESEARCH, 2017, 57 : 134 - 185
  • [3] Why pharmacokinetic model drug delivery?
    Reves, JG
    Jacobs, JR
    Sladen, R
    INTERNATIONAL ANESTHESIOLOGY CLINICS, 1995, 33 (03) : 29 - 43
  • [4] OCULAR DRUG DELIVERY - PHARMACOKINETIC CONSIDERATIONS
    SCHOENWALD, RD
    CLINICAL PHARMACOKINETICS, 1990, 18 (04) : 255 - 269
  • [5] PHARMACOKINETIC EVALUATION OF REGIONAL DRUG DELIVERY
    ERIKSSON, UG
    TOZER, TN
    ACTA PHARMACEUTICA JUGOSLAVICA, 1987, 37 (04): : 331 - 344
  • [6] Pharmacokinetic considerations for targeted drug delivery
    Yamashita, Fumiyoshi
    Hashida, Mitsuru
    ADVANCED DRUG DELIVERY REVIEWS, 2013, 65 (01) : 139 - 147
  • [7] PHARMACOKINETIC MODEL OF TRANSCORNEAL DRUG DELIVERY
    TOJO, K
    MATHEMATICAL BIOSCIENCES, 1988, 89 (01) : 53 - 77
  • [8] Pharmacokinetic studies for cochlear drug delivery
    Park, Kinam
    JOURNAL OF CONTROLLED RELEASE, 2019, 299 : 165 - 165
  • [9] A pharmacokinetic model for ocular drug delivery
    Tojo, K
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2004, 52 (11) : 1290 - 1294
  • [10] Formulation and pharmacokinetic evaluation of a paclitaxel nanosuspension for intravenous delivery
    Wang, Yonglu
    Li, Xueming
    Wang, Liyao
    Xu, Yuanlong
    Cheng, Xiaodan
    Wei, Ping
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2011, 6 : 1497 - 1507